Abstract-Animal models of mental disorders should ideally have construct, face, and predictive validity, but current animal models do not always satisfy these validity criteria. Additionally, animal models of depression rely mainly on stress-induced behavioral changes. These stress-induced models have limited validity, because stress is not a risk factor specific to depression, and the models do not recapitulate the recurrent and spontaneous nature of depressive episodes. Although animal models exhibiting recurrent depressive episodes or bipolar depression have not yet been established, several researchers are trying to generate such animals by modeling clinical risk factors as well as by manipulating a specific neural circuit using emerging techniques.
INTRODUCTION
Depression imposes a large social burden due to substantial impairment and disability in everyday activities at work, school, and home; the limited efficacy of existing treatments; and a high rate of lifetime prevalence. Depression is also a risk factor for somatic diseases such as cardiovascular disease (Lin et al., 2014) , and maternal depression has been shown to affect child development (Ohoka et al., 2014) .
Approximately 16% of patients seeking treatment for a major depressive episode have bipolar disorder (Angst et al., 2011) . Bipolar disorder is characterized by recurrent depressive and (hypo)manic episodes. The course of bipolar disorder is dominated by the depressive state (Judd et al., 2002 (Judd et al., , 2003 . Though bipolar depression is associated with characteristic features such as early onset, psychotic symptoms, hypersomnia, and hyperphagia (Mitchell et al., 2008) , there is no ''point of rarity" between depressive states of unipolar depression and bipolar disorder.
All the currently available antidepressants share a fundamental mechanism of action, i.e., the modulation of monoaminergic neurotransmission . Studies concerned with the development of new antidepressants with novel mechanisms of action have had limited success. This may be partly due to the lack of adequate animal models of depression and less knowledge about the disease mechanism, which are almost two sides of the same coin.
Although antidepressants were developed to ameliorate the symptoms of acute depression and approved based on this efficacy (Inada and Inagaki, 2015) , they are also prescribed to prevent relapses (Piek et al., 2014) . Almost half of the patients that recover from major depressive episodes experience relapse (Belsher and Costello, 1988) .
Several drugs, such as lithium, lamotrigine, olanzapine, quetiapine, and aripiprazole, are known to have preventive effects for bipolar disorder (Kanba et al., 2013) , some of which might also be effective for unipolar depression (Zhou et al., 2015) . However, none of these drugs were developed specifically for bipolar disorder; they were developed for schizophrenia or epilepsy with their uses extended to the treatment of bipolar disorder.
This lack of novel treatment specifically designed for the prevention of mood episodes in recurrent depression and bipolar disorder is due at least in part to the lack of animal models exhibiting spontaneous episodes of depression and/or mania. The development of new animal models exhibiting recurrent spontaneous mood episodes is therefore indispensable for the development of new drugs that are effective in the prevention of mood episodes.
In this article, the issues surrounding animal models of recurrent or bipolar depression are discussed.
CAN MOOD DISORDERS BE MODELED BY ANIMALS?
An animal model of mental disorder should ideally satisfy three validity criteria: construct, face, and predictive validity (Kato et al., 2007; Nestler and Hyman, 2010) . In reality, most researchers utilize models that satisfy only a subset of these three criteria.
Construct validity
Construct validity refers to how the mechanism of a disease is shared between a disease and the model. Recurrent depression and bipolar disorder are widely thought to be caused by gene-environment interactions. One ideal animal model would be genetically modified animals carrying a genetic mutation that confers a strong risk of a disease with high penetrance. However, research has yet to identify the genes that exert a strong effect on recurrent depression and bipolar disorder (Kato, 2015) , and many patients do not have such mutations with strong effects. Thus, the other ideal model would be an animal model that is created by gene-environment interaction, in which a genetic model of a common polymorphism is exposed to an environmental risk factor interacting with the polymorphism. Among environmental factors, perinatal infection (Parboosing et al., 2013) , maternal smoking during pregnancy (Talati et al., 2013) , and perinatal complications are established risk factors for bipolar disorder, but also apply to schizophrenia (Schmitt et al., 2014) . Childhood maltreatment also is a common risk factor for depression and bipolar disorder (Daruy-Filho et al., 2011) as well as other mental disorders, such as personality and anxiety disorders.
Psychosocial stress is a risk factor for depressive episodes, and is frequently used in animal models, despite the fact that it is common to both mental disorders and general medical illnesses. For example, social defeat stress, which is currently widely used as an animal model for depression in neuroscience research (Tsankova et al., 2006) , was initially developed for the study of hypertension (Henry et al., 1967) . Additionally, the learned helplessness model, which is frequently used in the study of depression, is also used for the study of gastric ulcers (Pare and Redei, 1993) . When stress-induced animal models are used for depression research, the confounding effects of somatic factors should also be considered.
Thus, as discussed above, many of the current animal models rely on limited construct validity.
Face validity
Face validity refers to how the signs and symptoms in animal models are similar to the disease. In clinical settings, recurrent depression and bipolar disorder are defined by the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, fifth edition) criteria (American Psychiatric Association, 2013). The DSM-5 criteria for depressive and manic episodes contain several items that rely solely on subjective experience. These include ''depressed mood," ''feelings of worthlessness," and ''thoughts of death" for major depressive episodes, and ''elevated mood," ''increased self-esteem," and ''flight of ideas" for manic episodes. Therefore, face validity is perhaps more difficult to attain in animal models than the other mentioned criteria. Nonetheless, it should be noted that certain symptoms of depressive and manic episodes, such as sleep disturbances, appetite changes, and agitation/retardation can be reasonably defined, even in animals, by means of behavioral or physiological measurements. For example, sleep disturbances have been detected by electroencephalography (Moreau et al., 1995) , and increases in food cravings have been detected by the progressive ratio operant procedure (Willner et al., 1998) in the chronic mild stress model. We used a behavioral test battery to assess the behavioral phenotype of Wfs1 knockout mice, a possible animal model of depression, and found that the mice showed an increased latency to movement in the passive avoidance test and a longer escape latency in the Morris water maze task in spite that there was no difference of the distance traveled. We interpreted these findings as reflective of psychomotor retardation, that is, slow voluntary movement (Kato et al., 2008) . Therefore, we should examine whether an animal model meets the clinical criteria for depression or mania as far as possible. Needless to say, there are fundamental differences in behavioral characteristics between humans and other animals. For example, humans are diurnal whereas many animals used as animal models are nocturnal. These behavioral differences between species should be taken into consideration.
In addition to modeling the symptoms of depression and mania, it is important to model the clinical course of these diseases. In the DSM-5 criteria, major depressive disorder, recurrent, and bipolar I (or II) disorder are defined by characteristic clinical courses that consist of combinations of major depressive and/or (hypo)manic episodes.
DSM-5 is defined by signs and symptoms that either a physician can observe or a patient experiences. Recently, the National Institute of Mental Health of the United States has started to use Research Domain Criteria (RDoC) instead of DSM-5 criteria for research purposes (Casey et al., 2013) . RDoC defines mental disorder by behavioral and neurobiological measures on five domains: Negative Valence Systems, Positive Valence Systems, Cognitive Systems, Systems for Social Processes, and Arousal/ Regulatory Systems. Some measures in these domains might reflect endophenotypes (Insel and Cuthbert, 2009) . Though the RDoC is not intended for use to diagnose patients, if this approach is successful, RDoC might facilitate the translation of research findings from animals to humans and vice versa, because these behavioral and neurobiological measures could be assessed equally in animals and humans.
It is also important to note that behavioral changes characteristic to depression also can be caused by general disease. As is the case for the learned helplessness test noted above, stress exposure can affect not only brain function but also gastrointestinal, cardiac, and other organ functions. It is therefore important to rule out the direct effects of impairment of other organs on model behavior.
Predictive validity
Predictive validity refers to the commonality of the effect of medications on a disease and behaviors of an animal model of the disease. Some past depression models, such as the olfactory bulbectomized (OB) rat, have relied solely on predictive validity. Olfactory bulbectomies have been shown to cause hyperactivity and aggression symptoms in rats, which are improved by the administration of antidepressants (Kelly et al., 1997) . In the case of the OB rat as a model of depression, predictive validity was emphasized, and face and construct validities were ignored. Another problem encountered in animal models of depression is the duration of action of the antidepressants. In clinical settings, antidepressants exert their effect after a week of treatment. However, in the case of the widely cited forced swimming test, antidepressants were administered just before the animals were made to swim (Porsolt et al., 1977) . In this case, we should be prudent about claiming that the efficacy of this test accurately reflects the clinical action of the drugs being tested. On the other hand, chronic antidepressant treatment is required for the efficacy observed on the novelty-suppressed feeding test (Bodnoff et al., 1988) . However, this test is for anxiety rather than depression. Notably, the requirement of neurogenesis is different between the forced swimming and novelty-suppressed feeding tests such that neurogenesis is not necessary in the former test (Holick et al., 2008) but is necessary in the latter test (Santarelli et al., 2003) . Therefore, one should consider which behavioral test is the best suited to test the predictive validity of an animal model.
It should be noted that predictive validity is not always necessary, because many patients are resistant to currently available drugs, and drugs for such refractory patients should be developed using new animal models.
DEPRESSION MODELS
The representative animal models of depression are summarized in Table 1 .
The forced swimming test is the most popular paradigm among the listed models, as is indicated by the extremely high number of citations of the original report. The forced swimming and tail suspension tests share the common feature of apparent ''behavioral despair." However, it has been noted that immobility in these tests does not always indicate behavioral despair, but rather reflects a successful energy-saving coping strategy (West, 1990 ). These models should therefore not be considered genuine ''depression models," but rather may be tests for antidepressant drugs acting on monoaminergic systems (Reneric and Lucki, 1998) .
Whereas the learned helplessness (Maier and Seligman, 1976) , chronic unpredictable stress (Willner et al., 1987) , and social defeat models (Henry et al., 1967) are used to investigate behavioral changes after acute or chronic stress, the maternal separation (Plotsky and Meaney, 1993) , prenatal stress (Mueller and Bale, 2008) , and neonatal clomipramine administration (Mirmiran et al., 1980) models are used to investigate perinatal or early environmental risk factors.
Other models include the immune activation model (Yirmiya, 1996) , which is used to evaluate sickness behavior associated with infection, and the dorsal raphespecific serotonin transporter (HTT) knockout mice (Lira et al., 2003) and Flinders Sensitive Line (FSL) rats (Overstreet, 1986) , both of which are used to model genetic factors. In addition, as noted above, the OB rat model (Cairncross et al., 1977) is not based on construct validity.
The neurobiological basis of depression has been extensively studied through stress-related models (Krishnan and Nestler, 2008) . For example, the neuroplastic theory of depression was established based on the restraint stress model (Pittenger and Duman, 2008) . Additionally, each model exhibits a different response to antidepressants. For example, antidepressant response is dependent on the behavioral paradigm in the maternal separation model (Harrison and Baune, 2014) , whereas the chronic unpredictable stress model responds well to chronic antidepressant treatment . Though many of the current animal models of depression utilize stress exposure as noted above, the effect of stress decreases with the progression of the illness, and repeated exposure to stress can lead to depressive episodes occurring spontaneously and independently from stressful life events (Post, 1992) .
NEURAL CIRCUIT MODELS OF DEPRESSION
The above noted approaches have tried to model clinical risk factors of depression such as psychosocial stress, somatic factors, early adversity, perinatal environmental factors, and genetic vulnerability. Meanwhile, the development of optogenetics, a new technology to manipulate specific neural circuits in living organisms using opsins expressed by transgenes and light illumination to specific brain regions, has enabled the analysis of the role of specific neural circuits in specific behaviors in living animals (Boyden et al., 2005) . In particular, the role of neural circuits involving the amygdala in anxiety-related behaviors has been extensively studied using this technology (Deisseroth, 2014) . This emerging technology enables a new type of animal model, i.e., ''neural circuit models" of depression.
In this model, instead of satisfying the construct validity by imposing risk factors for depression, neurophysiological phenomena that are proposed to occur in the brains of patients with depression are directly simulated. Whereas electric stimulation or lesion studies are able to examine the net effect of excitatory and inhibitory neurons on a particular brain area, optogenetics can examine the role of a specific group of neurons projecting from one brain region to the other; for example, from the medial prefrontal cortex (mPFC) to the dorsal raphe nucleus (DRN) (Warden et al., 2012) . Furthermore, the high temporal resolution of optogenetics enables the analysis of the relationship between the stimulation of a group of neurons with different firing patterns and the behavioral consequence (Chaudhury et al., 2013) .
Because the neural circuit mechanism of depression has not yet been fully elucidated, the manipulation of a candidate neural circuit is employed for this type of study.
Role of dorsal raphe serotonergic neurons
Antidepressants are thought to exert their effect by enhancing serotonergic neurotransmission, but corresponding neural circuit abnormalities in depression are not yet well understood.
The stimulation of the axons of the mPFC neurons in the DRN increased swimming behavior during forced swimming (Warden et al., 2012 ), but did not increase locomotor activity in an open-field test, which implicates a specific role of the mPFC-DRN neural projection in the immobility behavior observed during the forced swimming test.
The optogenetic inhibition of GABAergic neurons in the DRN prevented the acquisition of social avoidance after social defeat (Challis et al., 2013) , suggesting a role of DRN inhibitory neurons in the susceptibility phenotype. DRN GABAergic neurons receive inputs from the ventromedial prefrontal cortex (vmPFC) (Challis et al., 2014) , and optogenetic stimulation of these inputs enhanced avoidance that resembled the resilient phenotype induced by social defeat stress, whereas optogenetic inhibition diminished the avoidance behavior.
In human experiments, serotonin deficiency in the brain via tryptophan depletion increased delayed reward discounting, and it was speculated that this might play a role in depression (Schweighofer et al., 2008) . The selective activation of DRN serotonergic neurons during a delayed reward task decreased the premature cessation of waiting. The effect of increased waiting time was not due to motor inhibition, and was not mediated by the rewarding effect of serotonergic neuron stimulation (Miyazaki et al., 2014) . This finding has been replicated by other investigators (Fonseca et al., 2015) .
Therefore, findings from the optogenetic manipulation of serotonergic neurons might shed light on the role of serotonin in depression.
Role of ventral tegmental area dopaminergic neurons
The role of dopamine in depression is suggested by decreased homovanillic acid, a metabolite of dopamine, in the cerebrospinal fluid of depressed patients, and the effects of some antidepressants on dopaminergic systems (Kunugi et al., 2015) .
The inhibition of ventral tegmental area (VTA) dopaminergic neurons in mice results in ''depressionlike" behaviors such as increased immobility time in the tail suspension test and decreased sucrose preference (Tye et al., 2013) . The stimulation of VTA dopaminergic neurons counteracted the increase in immobility time and the decrease in sucrose preference due to chronic mild stress (Tye et al., 2013) .
However, the phasic stimulation of VTA dopaminergic neurons in mice that experienced subthreshold social defeat stress induced a susceptible phenotype, whereas tonic stimulation did not (Chaudhury et al., 2013) . Therefore, this experiment directly proves the role of VTA dopaminergic neurons in the susceptible phenotype after social defeat stress, which was suggested by previous studies (Cao et al., 2010) .
Although these two studies show apparently opposite effects of dopaminergic neurotransmission on depression, depression should not be considered a single homogeneous disease but rather a syndrome comprised of a variety of diseases with different neurobiological mechanisms.
Future directions
As discussed above, past optogenetic studies have demonstrated the significance of candidate neural circuits in ''depression-like" behaviors, such as immobility in forced swimming and susceptibility to social defeat stress (Warden et al., 2012; Chaudhury et al., 2013; Tye et al., 2013) . The manipulated neural circuits are candidate neural circuits implicated from the action mechanism of antidepressants on the serotonergic and dopaminergic systems.
Most importantly, none of the neural circuit models has tested recurrent depressive episodes. To examine the long-term consequence of neural circuit manipulation, other techniques such as DREADD (designer receptors exclusively activated by designer drugs) (Urban and Roth, 2015) or DICE-K (doxycyclineinhibited circuit-exocytosis knockdown) (Nakashiba et al., 2008) would also be suitable. In DREADD, receptors that are designed to be activated or inactivated by a designer drug are expressed in a specific neural circuit, and a designer drug CNO (clozapine N-oxide) is administered to stimulate or inhibit this neural circuit. In DICE-K, tetanus toxin, which inhibits exocytosis, is expressed in a specific neural circuit to inhibit neural transmission depending on doxycycline.
If future studies of genetic animal models identify novel causative neural circuits, neural circuit manipulation by emerging techniques such as optogenetics will be useful to test whether the given neural circuit is responsible for depression (Tye et al., 2013) . Though these new technologies are promising, difficulties in assessing face validity remain major problems in the study of neural circuit models.
CURRENT STATUS OF ANIMAL MODELS OF BIPOLAR DISORDER
There have been no established animal models of bipolar disorder that exhibit both manic and depressive episodes. Typical current animal models of mania involve druginduced hyperactivity or genetically modified animals that exhibit continuous hyperactivity.
The most popular animal model of mania is the amphetamine-induced hyperactivity model (Kara and Einat, 2013) . Hyperactivity caused by intracerebroventricular injection of ouabain also has been used in animal models of mania (el-Mallakh et al., 1995) , based on the hypothesis that Na + /K + -ATPase dysfunction is a feature of bipolar disorder. Although genetically modified mice exhibiting hyperactivity might also be considered animal models of mania (Kara and Einat, 2013) , these mice are sometimes considered to be animal models of attention deficit/hyperactivity disorder (ADHD) as well (Russell, 2007) . Furthermore, hyperactive mice also are considered to be animal models of schizophrenia (Gainetdinov et al., 2001) . Therefore, persistent hyperactivity observed in mutant mice is not necessarily indicative of an accurate animal model of mania, and construct and predictive validity should be emphasized in these cases.
In this regard, the Shank3 overexpression model is of exceptional interest. Han and colleagues generated Shank3 transgenic mice based on the fact that the duplication of chromosomal region 22q13, including the SHANK3 gene, is associated with neurodevelopmental disorders such as autism spectrum disorders, ADHD, and schizophrenia. In addition, Shank3 has been identified as a plausible candidate gene for these phenotypes . Because mice overexpressing Shank3 exhibit hyperactivity, the authors interpreted this finding as reflective of an ADHD symptom. However, this condition was worsened by amphetamine treatment, which runs contrary to the initial expectation that amphetamine treatment would improve the hyperactivity as is the case in patients with ADHD. To determine the reason for this unexpected experimental result, the authors closely examined the clinical records of two patients carrying a duplication of SHANK3. They found that one patient had epilepsy and ADHD that was nonresponsive to psychostimulants, and the other patient had epilepsy and bipolar disorder. This clinical observation was consistent with the lack of efficacy of amphetamine in their model mice. Instead, they speculated that valproate, an antiepileptic drug that is also effective for mania, might be effective for their model mice. Indeed, valproate was effective in treating the hyperactivity of the mice. These findings suggest that mice with Shank3 overexpression could serve as a model of valproateresponsive mania.
ANIMAL MODELS OF RECURRENT MOOD EPISODES
None of the animal models described above exhibit spontaneous recurrent mood episodes. A literature search using the keywords ''recurrent depression" and ''animal model" yielded no relevant papers. However, to the best of our knowledge, some studies do convey the possibility of creating animal models that can be used to investigate spontaneous mood episodes (Table 2) . Model mice carrying a dominant negative mutation of the Clock gene have been utilized as animal models of mania (Roybal et al., 2007) . These mice exhibit persistent hyperactivity, reduced behavioral despair, reduced anxiety, sleep disturbances, and an increase in the reward values of cocaine, sucrose, and intracranial selfstimulation of the medial forebrain bundle. These phenotypes were persistent rather than episodic, and some of these behavioral features were normalized by lithium treatment. However, since the manic-like phenotype observed during the day disappeared at night, the researchers speculated that the phenotype of the mice is reflective of rapid mood cycling (Sidor et al., 2015) . Remus and colleagues speculated that the experience of a prior depressive episode would increase susceptibility to future depressive episodes. To test this hypothesis, they applied chronic mild stress to rats for 35 days, while controls were kept in their home cage. After a 20-day recovery period, both groups of rats were exposed to a second session of chronic mild stress for 15 days. The rats that had experienced the first stress session exhibited a more rapid decline in sucrose consumption when compared with controls (Remus et al., 2013) . The researchers discussed this phenomenon as a model of recurrent depression.
Honma and colleagues chronically treated rats with methamphetamine by adding it to their drinking water. Some of the rats failed to entrain to the light/dark cycle, and exhibited a free-running period longer than 24 h (Honma et al., 1986) . Rats with suprachiasmatic nucleus lesions treated with chronic methamphetamine occasionally exhibited a circabidian, i.e., an approximately 48-h, activity rhythm (Honma et al., 1992) . These researchers are currently studying the neurobiological basis of bipolar disorder using this model (Honma et al., 2014) .
Yamasaki et al. analyzed a mouse model characterized by a heterozygous mutation of alpha calcium/calmodulin-dependent protein kinase II. These mice exhibited hyperactivity periods over an approximately 1-2-week cycle (Yamasaki et al., 2008) . The researchers posited that this activity pattern resembled periodic mood changes, which may be similar to bipolar disorder.
The similarity between seasonal affective disorder and hibernation has been discussed in the literature (Mrosovsky, 1988) . Hibernation has not been observed in mutant mice, but a related phenomenon known as daily torpor has been reported in a mutant mouse line. Mice carrying mutant prokineticin receptor 2 (Prokr2) exhibited spontaneous and recurrent bouts of decreased locomotor activity with a hypometabolic state lasting approximately 8 h at room temperature (Jethwa et al., 2008) .
Kasahara and colleagues generated transgenic mice with mutant mitochondrial DNA polymerase (Polg) to model psychiatric symptoms observed in patients with a mitochondrial disease, chronic progressive external ophthalmoplegia. The mice exhibited an altered day/ night activity rhythm and periodic changes in wheel running activity associated with the estrous cycle. These phenotypes were normalized by lithium treatment. Treatment with tricyclic antidepressants increased activity levels. These findings suggest that mice are able to exhibit mood disorder-like phenotypes (Kasahara et al., 2006) .
CONCLUSION
Past animal models of depression have relied primarily on stress-induced behavioral changes. No current animal models have been established as accurate models of recurrent or bipolar depression. This is partly due to the lack of established causative genetic mutations of recurrent depression or bipolar disorder. In order to model recurrent depression or bipolar disorder in animals, we must first identify the genetic mutations that strongly confer a risk for these disorders. Recent findings have shown that de novo mutations play a role in schizophrenia (Fromer et al., 2014; Takata et al., 2014) , and identification of the de novo mutations that cause recurrent depression and bipolar disorder would enable further genetic modeling in animals. Furthermore, behavioral characterizations should refer to the clinical definitions of recurrent depression and bipolar disorder in humans as the ''gold standard" to define mental disorders. To date, none of the animal models of recurrent depression or bipolar disorder has been assessed using DSM-5 or other clinical criteria. Further consideration should be given as to how clinical diagnoses in humans can be introduced into animal model studies, while taking into account the differences in behavioral characteristics among species.
